Cargando…
Pathogenic potential of interferon αβ in acute influenza infection
Influenza symptoms vary from mild disease to death; however, determinants of severity are unclear. Type I interferons (IFNαβ) are recognized as key antiviral cytokines. Here we show that, surprisingly, influenza-infected 129 mice have increased lung damage, morbidity and mortality, yet higher levels...
Autores principales: | Davidson, Sophia, Crotta, Stefania, McCabe, Teresa M, Wack, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Pub. Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033792/ https://www.ncbi.nlm.nih.gov/pubmed/24844667 http://dx.doi.org/10.1038/ncomms4864 |
Ejemplares similares
-
IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment
por: Davidson, Sophia, et al.
Publicado: (2016) -
Type I and III interferons disrupt lung epithelial repair during recovery from viral infection
por: Major, Jack, et al.
Publicado: (2020) -
Type I and Type III Interferons Drive Redundant Amplification Loops to Induce a Transcriptional Signature in Influenza-Infected Airway Epithelia
por: Crotta, Stefania, et al.
Publicado: (2013) -
TRAIL(+) monocytes and monocyte-related cells cause lung damage and thereby increase susceptibility to influenza–Streptococcus pneumoniae coinfection
por: Ellis, Gregory T, et al.
Publicado: (2015) -
A TLR7 antagonist restricts interferon-dependent and -independent immunopathology in a mouse model of severe influenza
por: Rappe, Julie C.F., et al.
Publicado: (2021)